Eisai Co Ltd (ESAIY)
10.92
-0.23
(-2.06%)
USD |
OTCM |
May 16, 16:00
Eisai Accounts Payable (Quarterly): 525.28M for Dec. 31, 2022
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 525.28M |
September 30, 2022 | 531.80M |
June 30, 2022 | 703.59M |
March 31, 2022 | 885.38M |
December 31, 2021 | 787.68M |
September 30, 2021 | 681.38M |
June 30, 2021 | 730.70M |
March 31, 2021 | 857.08M |
December 31, 2020 | 680.56M |
September 30, 2020 | 737.17M |
June 30, 2020 | 575.00M |
March 31, 2020 | 711.36M |
December 31, 2019 | 553.53M |
September 30, 2019 | 489.73M |
June 30, 2019 | 540.55M |
March 31, 2019 | 699.21M |
December 31, 2018 | 465.75M |
September 30, 2018 | 458.40M |
June 30, 2018 | 476.33M |
March 31, 2018 | 640.78M |
December 31, 2017 | 512.85M |
September 30, 2017 | 500.80M |
June 30, 2017 | 496.29M |
March 31, 2017 | 632.79M |
December 31, 2016 | 568.77M |
Date | Value |
---|---|
September 30, 2016 | 571.82M |
June 30, 2016 | 530.06M |
March 31, 2016 | 501.78M |
December 31, 2015 | 411.45M |
September 30, 2015 | 404.02M |
June 30, 2015 | 433.89M |
March 31, 2015 | 704.69M |
December 31, 2014 | 412.43M |
September 30, 2014 | 466.05M |
June 30, 2014 | 559.98M |
March 31, 2014 | 604.73M |
December 31, 2013 | 248.94M |
September 30, 2013 | 265.99M |
June 30, 2013 | 265.75M |
March 31, 2013 | 276.69M |
December 31, 2012 | 282.57M |
September 30, 2012 | 837.37M |
June 30, 2012 | 989.35M |
March 31, 2012 | 318.39M |
December 31, 2011 | 884.68M |
September 30, 2011 | 818.05M |
September 30, 2011 | 818.05M |
June 30, 2011 | 792.39M |
March 31, 2011 | 822.60M |
December 31, 2010 | 930.54M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
489.73M
Minimum
Sep 2019
885.38M
Maximum
Mar 2022
666.05M
Average
681.38M
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
Biogen Inc | 387.00M |
Takeda Pharmaceutical Co Ltd | 3.617B |
Nxera Pharma Co Ltd | 20.37M |
PeptiDream Inc | 19.91M |
Healios KK | 2.669M |